Furin as a therapeutic target in cystic fibrosis airways disease.
Journal Information
Full Title: Eur Respir Rev
Abbreviation: Eur Respir Rev
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Pulmonary Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Conflict of interest: S.L. Martin has received research grants from Boston Pharmaceuticals, who have a furin inhibitor programme in development. The remaining authors have no conflicts to disclose."
"Support statement: L.E.J. Douglas is supported by a project grant funded by Boston Pharmaceuticals and B.M. Montgomery by a collaborative PhD studentship funded by the Department of the Economy, Northern Ireland and Boston Pharmaceuticals (to S.L. Martin). J.A. Reihill is funded via an MRC Innovation Scholar Award (grant reference MR/W004135/1 to J.A. Reihill and S.L. Martin). Funding information for this article has been deposited with the Crossref Funder Registry."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025